Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sc…
$2.90+4.89%
报价 2026-11-06
市值
$136.9M
EV
$128.7M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -64.1%
$2.42$8.06
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| QTRXQuanterix Corporation | $136.9M | +4.9% | +27.6% | 42.6% | – | – | – | |
| SGHTSight Sciences, Inc. | $555.3M | +3.3% | +11.3% | 88% | – | – | – | |
| SENSSenseonics Holdings, Inc. | $454.2M | +7.5% | +77.0% | 54.9% | – | – | – | 高增长 |
| MASS908 Devices Inc. | $436.5M | +4.0% | +25.6% | 49.8% | – | – | 911.9x | |
| VMDViemed Healthcare, Inc. | $347.7M | +1.3% | +16.7% | 57% | 23.4x | 6.9x | 28.7x | GARP |
| IMRXImmuneering Corporation | $238.3M | +9.2% | +1836.4% | 0% | – | – | – | |
| INGNInogen, Inc. | $160M | -10.9% | +4.9% | 48.9% | – | – | – | |
| OMOutset Medical, Inc. | $79.5M | +3.2% | +8.0% | 41.8% | – | – | – | |
| CVRXCVRx, Inc. | $23.1M | -40.9% | +15.8% | 86.6% | – | – | – | |
| 同行中位数 | – | – | +16.2% | 52.3% | 23.4x | 6.9x | 470.3x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。